CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

CVS HEALTH Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$92.68+0.32 (+0.35%)

Close on Oct 19, 2026

Market cap: $119.28B
P/E (TTM): 24.6
Dividend yield: 2.87%

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt

$61.41B

$1.96B due within a year

Net debt

$50.08B

After $11.33B of cash

Implied interest rate

4.77%

FY2025 interest ÷ average debt

Interest coverage

1.5×

FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Cvs Health's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Cvs Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 7, 2005
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CVS.

Revenue growth7.4% · median 7.1%

Gross margin44.5% · median 54.6%

Operating margin2.0% · median 3.1%

Net margin1.2% · median 2.5%

Company	Revenue	Growth
UNH	$450.13B	+6.5%
CVS	$415.09B	+7.4%
CI	$282.38B	+7.8%
CAH	$244.67B	+10.1%
ELV	$201.11B	+6.3%
YI	–	–

Company

Next earnings (est.): Oct 28, 2026, before open
Exchange: NYSE
Industry: Retail-Drug Stores and Proprietary Stores
Fiscal year ends: December 31
Employees: 300,000
Held by institutions: 89.2%
Auditor: Ernst & Young LLP
SEC CIK: 64803

Advertisement
300 × 250